SCHEMBL976668

SCHEMBL976668

CC(C)(O)c1ccc(C2(c3ccc(-c4ccc(N)nn4)cc3)CCCCC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 5/20 0.48
ALDH1A1 P00352 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ESR1 P03372 3/20 0.36
ESR2 Q92731 3/20 0.36
ALOX5AP P20292 3/20 0.34
OPRM1 P35372 1/20 0.33
OPRD1 P41143 1/20 0.33
OPRK1 P41145 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
ALOX12 P18054 1/20 0.32
HTT P42858 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
GSK3A P49840 1/20 0.32
SLC6A2 P23975 2/20 0.32
SLC6A4 P31645 2/20 0.32
SLC6A3 Q01959 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL978617 0.80 HSD11B1 (0.37) HSD11B1ESR1ESR2OPRM1OPRD1
SCHEMBL2990063 0.75 ALOX5AP (0.52) HSD11B1ALOX5APSYK
SCHEMBL3001060 0.67 ALOX5AP (0.64) ALOX5AP
SCHEMBL480207 0.66 ALOX5AP (0.65) ALOX5APSYK
SCHEMBL480232 0.66 ALOX5AP (0.65) ALOX5APSYK
SCHEMBL10351217 0.66 ALDH1A1 (0.71) ALDH1A1L3MBTL1ESR1ESR2OPRM1
SCHEMBL2131597 0.65 KIF11 (0.50) ALOX5APLMNA
SCHEMBL977392 0.64 ESR1 (0.49) HSD11B1ALDH1A1L3MBTL1ESR1ESR2
SCHEMBL11152421 0.63 ESR1 (0.65) ALDH1A1L3MBTL1ESR1ESR2ADORA3
SCHEMBL18802843 0.63 ACHE (0.50) ALDH1A1L3MBTL1ESR1ESR2OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110003815-A1 DIPHENYL SUBSTITUTED CYCLOALKANES MERCK & CO., INC. 2011-01-06 US disclosed
US-20110003815-A1 DIPHENYL SUBSTITUTED CYCLOALKANES MERCK & CO., INC. 2011-01-06 US disclosed
US-20110003815-A1 DIPHENYL SUBSTITUTED CYCLOALKANES MERCK & CO., INC. 2011-01-06 US disclosed
WO-2009048547-A1 DIPHENYL SUBSTITUTED CYCLOALKANES MERCK & CO., INC. (US) 2009-04-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003815-A1 DIPHENYL SUBSTITUTED CYCLOALKANES PTGIS, PTGS1, LTC4S HSD11B1 252/4885ALDH1A1 292/4885L3MBTL1 3046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.